State-of-the-art clinical research to focus on patients worldwide

Worldwide, researchers are conducting many national and international deep Real-World Evidence studies using EHRead© predictive models.

1 - Therapeutic Areas

Cardiology

  • Anticoagulants in Atrial Fibrillation Closed
  • Coronary disease and Diabetes Mellitus type II Closed

Endocrinology

  • Diabetes Mellitus Type I & II Closed
  • Hyperparathyroidism Closed

Hematology

  • Chronic Lymphocytic Leukemia Closed
  • Multiple Myeloma Closed

Ophthalmology

  • Conjunctivitis Closed

Traumatology & Orthopedics

  • Hip Fractures Closed

2 - The Oncology Initiative

Improving outcomes for patients with cancer

At present, Savana is conducting several oncology research studies, investigating different primary tumors. The latest international project has just been launched in collaboration with the Head and Neck Cancer International Group (HNCIG) and it is currently open to researchers and hospital recruitment. HNC-TACTIC a multi-language, multi-center, deep Real-World evidence study analyzing the information captured in Electronic Health Records aiming to generate two predictive models to improve head and neck cancer patients outcomes, among other analysis.

3 - The Respiratory Initiative

Improving outcomes for patients with respiratory diseases

Savana’s BigCOPData study – supported by the European Commission – spans patients with COPD in Europe, USA and Canada. The study aims to identify the factors associated with hospitalisation and develop a risk-prediction model for hospitalisation of these patients.

Savana has partnered with BREATHE – the Health Data Research Hub for respiratory health and are collaborating on the Big COVIData study, accelerating the use of data from de-identified electronic health records to monitor disease progression and outcomes in patients hospitalised with COVID-19. The newly-announced partnership will accelerate the use of data from de-identified EMRs to monitor disease progression and outcomes in UK patients hospitalised with COVID-19 as part of the international Big COVIData study.
Therefore, at present two respiratory international studies are open, enabling high-quality collaborative research and cutting-edge investigation on COPD and COVID to improve the lives of people living with respiratory conditions.

4 - What are our advantages?

Enter our research ecosystem

Savana’s deep Real-World Evidence Research Network is an increasing Real-World Evidence Ecosystem formed by 150+ hospitals across Europe, Canada, USA and Latin America.

Pioneers in global NLP-based Real-World Evidence studies, building a research community based on medical Artificial Intelligence. Sponsors and researchers from across the globe connect with their peers and promote their own collaborative research.

Use our AI tool kit

Savana Manager is an application created to visualise and export clinical data coming from a Hospital (Site) Electronic Health Records document base. This document base has relevant clinical information about the Site population. Savana Manager enables the user to openly query this document base on a structured way, using many terminologies and filters to obtain the desired population output.

Bringing Hospital IT department into the core team of a clinical research project.

Compatible with all kinds of healthcare provider information systems.

Enrol in a project

Request more information

Privacy Policy Summary

  • ControllerMedsavana S.L. (Calle Gran Vía nº30, planta 10, 28013 Madrid). Tax ID Code (C.I.F.): B87060943
  • PurposeManagement and provision of services, sending of commercial information and newsletter, responding to surveys and handling enquiries.
  • LegitimationExecution of services, consent of users, compliance with legal obligations and legitimate interest.
  • RecipientsNo data will be transferred to third parties unless legally required.
  • RightsAccess, rectification, erasure and other rights explained in the Privacy Policy.
  • AdditionalFor more information, please see our Privacy Policy.
*Required

Request White Paper

Privacy Policy Summary

  • ControllerMedsavana S.L. (Calle Gran Vía nº30, planta 10, 28013 Madrid). Tax ID Code (C.I.F.): B87060943
  • PurposeManagement and provision of services, sending of commercial information and newsletter, responding to surveys and handling enquiries.
  • LegitimationExecution of services, consent of users, compliance with legal obligations and legitimate interest.
  • RecipientsNo data will be transferred to third parties unless legally required.
  • RightsAccess, rectification, erasure and other rights explained in the Privacy Policy.
  • AdditionalFor more information, please see our Privacy Policy.
*Required